Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 209.5 GBX 2.44% Market Closed
Market Cap: 448.8m GBX
Have any thoughts about
Advanced Medical Solutions Group PLC?
Write Note

Advanced Medical Solutions Group PLC
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Advanced Medical Solutions Group PLC
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Advanced Medical Solutions Group PLC
LSE:AMS
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Short-Term Debt
ÂŁ887k
CAGR 3-Years
-30%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Cambridge Nutritional Sciences PLC
LSE:CNSL
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Advanced Medical Solutions Group PLC
Glance View

Market Cap
455.9m GBX
Industry
Health Care

Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. The company is headquartered in Winsford, Cheshire. The company went IPO on 2002-04-30. The firm operates through two business units for its sales, marketing and research and development (R&D) activities. Surgical business unit is focused on selling and marketing its branded products and are sold directly and through its distributors. Wound care business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company’s products include ActivHeal, LiquiBand and RESORBA. Its technologies include collagen, cyanoacrylates, internal sealants, oxidized cellulose, sutures, alginates, foams, hydrocolloid and hydrogel.

AMS Intrinsic Value
309.15 GBX
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Advanced Medical Solutions Group PLC's Short-Term Debt?
Short-Term Debt
0 GBP

Based on the financial report for Jun 30, 2024, Advanced Medical Solutions Group PLC's Short-Term Debt amounts to 0 GBP.

Back to Top